|
|
||||||||
The Annals of Thoracic Surgery, Vol 35, 277-279, Copyright © 1983 by The Society of Thoracic Surgeons
ME Lee, DH Sethna, CM Conklin, WE Shell, JM Matloff and RJ Gray
Elevation of levels of the myocardial-specific isoenzyme of creatine kinase
(CK-MB) in the immediate postoperative period in patients undergoing
coronary artery bypass grafting is usually associated with myocardial
necrosis. However, mean isoenzyme elevations of 18 +/- 2 IU/L (standard
error of the mean) were recently observed in 6 patients in the absence of
electrocardiographic or scintigraphic (technetium 99m stannous
pyrophosphate) evidence of perioperative myocardial infarction. To test the
hypothesis that surgical trauma of the atrium and aorta during cannulation
for cardiopulmonary bypass might contribute to elevated CK-MB levels,
biopsy of the right atrial appendage and aorta of 7 patients was done at
operation, the tissue samples were assayed for total creatine kinase (CK)
activity using the Rosalki technique, and for CK-MB using column
chromatography. The results indicate that the human atrium is a rich source
of CK, with the proportion of CK-MB similar to that present in the
ventricle (20%). In addition, technical considerations inherent in the
performance of coronary bypass surgery may result in release of CK-MB,
causing elevated serum enzyme levels in the post-coronary artery bypass
patient in the absence of myocardial infarction.
ARTICLES
CK-MB release following coronary artery bypass grafting in the absence of myocardial infarction
This article has been cited by other articles:
![]() |
M. Kuduvalli, N. Newall, A. Stott, A. D. Grayson, and B. M. Fabri Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac enzyme release and survival. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Engoren, R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah The association of elevated creatine kinase-myocardial band on mortality after coronary artery bypass grafting surgery is time and magnitude limited Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 114 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Backstrom, M. Goiny, U. Lockowandt, J. Liska, and A. Franco-Cereceda Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion J Appl Physiol, March 1, 2003; 94(3): 1122 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Costa, R. G. Carere, S. V. Lichtenstein, D. P. Foley, V. de Valk, W. Lindenboom, P. C.H. Roose, T. R. van Geldorp, C. Macaya, J. L. Castanon, et al. Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) Circulation, November 27, 2001; 104(22): 2689 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A Abdel Aziz, M. A Ali, D. G Roberts, N. Al Khaja, T. A Abdel Aziz, M. A Ali, D. G Roberts, and N. Al Khaja Troponin T as a Marker of Infarction During Coronary Bypass Surgery Asian Cardiovasc Thorac Ann, March 1, 2000; 8(1): 19 - 23. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |